Recent Investments/Transactions - Activist Investor

Quantum Cyber Aligns Strategy With Trump Administration's National Cyber Security Framework, Targets Acquisitions in Quantum and Cyber Defense Sectors

12 min read

9 min read

Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

8 min read

Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update

3 min read

Black Titan Secures $200 Million from a U.S.-Based Institutional Investor to Scale Its DAT+ Vision

3 min read

Why NovaBay Pharmaceuticals (NBY) Is Up 99.3% After Pivoting From Liquidation To Restructuring And Asset Sales

8 min read

Sow Good Inc. Announces $6.0 Million Private Placement, Strategic Asset Sale, and Leadership Transition to Support Continued Candy Operations and Future Growth:

1 min read

Indaptus Therapeutics Signs Securities Purchase Agreement With David Lazar

4 min read

KALA Bio’s Bold Move: A New Dawn?

13 min read

KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

13 min read

Why Did KALA BIO Shares Jump Over 22% After Hours?

17 min read

KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

5 min read

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

EMERYVILLE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay" or the "Company") announces that it has regained compliance with the NYSE American’s continued listing standards.